AliveGen USA
Thousand Oaks, California, United States
About AliveGen USA
They are focused on the discovery and development of novel biotherapeutics to combat the debilitating muscle and bone loss and the loss of functional capacity, as occurs in various neuromuscular diseases, cancer cachexia, congestive heart failure, geriatric sarcopenia and frailty, as well as in other chronic diseases, for which no approved therapies are currently available.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2015)
- Website: alivegen.com
- Phone: 805-480-9600
Industries & Categories
Biopharma
Canonical: https://fsome.com/organization/alivegen-usa-2536877 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.